GILEAD SCIENCES INC (GILD) Fundamental Analysis & Valuation

NASDAQ:GILD • US3755581036

Current stock price

131.65 USD
+0.81 (+0.62%)
At close:
132 USD
+0.35 (+0.27%)
After Hours:

This GILD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. GILD Profitability Analysis

1.1 Basic Checks

  • In the past year GILD was profitable.
  • In the past year GILD had a positive cash flow from operations.
  • In the past 5 years GILD has always been profitable.
  • GILD had a positive operating cash flow in each of the past 5 years.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • GILD has a better Return On Assets (14.42%) than 94.76% of its industry peers.
  • With an excellent Return On Equity value of 37.49%, GILD belongs to the best of the industry, outperforming 97.67% of the companies in the same industry.
  • The Return On Invested Capital of GILD (19.49%) is better than 97.28% of its industry peers.
  • GILD had an Average Return On Invested Capital over the past 3 years of 17.55%. This is significantly below the industry average of 28.06%.
  • The 3 year average ROIC (17.55%) for GILD is below the current ROIC(19.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GILD's Profit Margin of 28.90% is amongst the best of the industry. GILD outperforms 94.37% of its industry peers.
  • In the last couple of years the Profit Margin of GILD has grown nicely.
  • GILD's Operating Margin of 39.98% is amongst the best of the industry. GILD outperforms 97.67% of its industry peers.
  • GILD's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 78.83%, GILD belongs to the top of the industry, outperforming 83.69% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

6

2. GILD Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GILD is creating value.
  • Compared to 1 year ago, GILD has less shares outstanding
  • The number of shares outstanding for GILD has been reduced compared to 5 years ago.
  • The debt/assets ratio for GILD has been reduced compared to a year ago.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 4.30 indicates that GILD is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of GILD (4.30) is better than 72.43% of its industry peers.
  • The Debt to FCF ratio of GILD is 2.64, which is a good value as it means it would take GILD, 2.64 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.64, GILD belongs to the best of the industry, outperforming 93.01% of the companies in the same industry.
  • GILD has a Debt/Equity ratio of 0.97. This is a neutral value indicating GILD is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.97, GILD is doing worse than 75.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.3
ROIC/WACC2.12
WACC9.17%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD has a worse Current ratio (1.55) than 82.72% of its industry peers.
  • GILD has a Quick Ratio of 1.40. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of GILD (1.40) is worse than 83.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

5

3. GILD Growth Analysis

3.1 Past

  • GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • GILD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
  • Looking at the last year, GILD shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • The Revenue has been growing slightly by 3.58% on average over the past years.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.02% on average over the next years. This is quite good.
  • Based on estimates for the next years, GILD will show a small growth in Revenue. The Revenue will grow by 5.47% on average per year.
EPS Next Y8.48%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
EPS Next 5Y10.02%
Revenue Next Year3.45%
Revenue Next 2Y4.74%
Revenue Next 3Y4.91%
Revenue Next 5Y5.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

6

4. GILD Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.15 indicates a correct valuation of GILD.
  • GILD's Price/Earnings ratio is rather cheap when compared to the industry. GILD is cheaper than 94.76% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.64. GILD is valued slightly cheaper when compared to this.
  • GILD is valuated correctly with a Price/Forward Earnings ratio of 14.89.
  • Based on the Price/Forward Earnings ratio, GILD is valued cheaper than 95.73% of the companies in the same industry.
  • GILD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.36.
Industry RankSector Rank
PE 16.15
Fwd PE 14.89
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 95.15% of the companies in the same industry are more expensive than GILD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, GILD is valued cheaper than 96.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.28
EV/EBITDA 12.15
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of GILD may justify a higher PE ratio.
PEG (NY)1.91
PEG (5Y)5.72
EPS Next 2Y9.83%
EPS Next 3Y9.44%

7

5. GILD Dividend Analysis

5.1 Amount

  • GILD has a Yearly Dividend Yield of 2.51%. Purely for dividend investing, there may be better candidates out there.
  • GILD's Dividend Yield is rather good when compared to the industry average which is at 0.07. GILD pays more dividend than 98.83% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, GILD pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.51%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 3.30%.
  • GILD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • GILD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years10
Div Non Decr Years10
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • GILD pays out 47.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

GILD Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

NASDAQ:GILD (5/1/2026, 8:00:01 PM)

After market: 132 +0.35 (+0.27%)

131.65

+0.81 (+0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)02-10
Earnings (Next)05-07
Inst Owners92.8%
Inst Owner Change-0.07%
Ins Owners0.1%
Ins Owner Change1.55%
Market Cap163.41B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.54
Price Target162.01 (23.06%)
Short Float %1.84%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield 2.51%
Yearly Dividend3.22
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years10
Div Non Decr Years10
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)1.47%
PT rev (3m)17.65%
EPS NQ rev (1m)0.29%
EPS NQ rev (3m)-7.86%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.23%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 16.15
Fwd PE 14.89
P/S 5.55
P/FCF 17.28
P/OCF 16.31
P/B 7.2
P/tB N/A
EV/EBITDA 12.15
EPS(TTM)8.15
EY6.19%
EPS(NY)8.84
Fwd EY6.72%
FCF(TTM)7.62
FCFY5.79%
OCF(TTM)8.07
OCFY6.13%
SpS23.72
BVpS18.29
TBVpS-2.09
PEG (NY)1.91
PEG (5Y)5.72
Graham Number57.9132 (-56.01%)
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.3
F-Score8
WACC9.17%
ROIC/WACC2.12
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.48%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
EPS Next 5Y10.02%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.74%
Revenue Next 3Y4.91%
Revenue Next 5Y5.47%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year26.16%
EBIT Next 3Y11.46%
EBIT Next 5Y10.72%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GILD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


What is the profitability of GILD stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 8 / 10.


What is the expected EPS growth for GILEAD SCIENCES INC (GILD) stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GILD) is expected to grow by 8.48% in the next year.


Is the dividend of GILEAD SCIENCES INC sustainable?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 47.04%.